Altafluor benox 0.25%-0.4% DRP 5ML
Ended Awarded
- Contract number
- SPE2DR26FCYV9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,028
Award facts
- Contract value 100% obligated
- $2,028.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,028 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for ALTAFLUOR BENOX 0.25%-0.4% drops in 5mL quantities. The award, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, utilizes firm fixed-price pricing with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499,999,999 ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's global military healthcare supply chain, authorized to provide branded and generic prescription medications, biologics, vaccines, and medical consumables to military medical facilities worldwide. The company's established performance across numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for federal military medical operations. The PPV-G GEN V program represents part of the Defense Logistics Agency's broader $30.3 billion pharmaceutical acquisition strategy, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FCYV9?
SPE2DR26FCYV9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FCYV9 worth?
The government has obligated $2,028 on SPE2DR26FCYV9.
Is contract SPE2DR26FCYV9 an order under another contract?
Yes. SPE2DR26FCYV9 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYV9 competed?
The extent of competition for SPE2DR26FCYV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award